Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …

Background Blastic plasmacytoid dendritic-cell neoplasm (BPDCN) is an aggressive
hematologic cancer that is caused by transformed plasmacytoid dendritic cells that …

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized
by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other …

Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on
expert opinions, but they have not been validated. Here we present the validated EuroFlow …

The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …

Bone Marrow Pathology has been extensively revised to reflect the significant advances
which have occurred in the application of cytogenetics and in particular, molecular genetics …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from
precursors of plasmacytoid dendritic cells. Cutaneous involvement represents often the first …

The purpose of this study is to describe the clinical and prognostic features and to evaluate
the outcome of different therapeutic approaches among patients with blastic plasmacytoid …